Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses
- PMID: 20006311
- DOI: 10.1016/S1472-9792(09)70017-4
Mycobacterium tuberculosis ESX-1 system-secreted protein ESAT-6 but not CFP10 inhibits human T-cell immune responses
Abstract
The secreted proteins of M. tuberculosis, early secreted antigenic target 6 kDa (ESAT-6) and culture filtrate protein 10 kDa (CFP10), have been identified as antigenic proteins with potent T-cell stimulatory effects, and therefore have been the focus of tuberculosis vaccine studies. However, recent work showed that secretion of these proteins by the specialized ESAT-6 secretion system (ESX)-1 of M. tuberculosis is associated with virulence and pathogenesis. The studies demonstrated that ESAT-6 inhibits antigen-presenting cell function by reducing IL-12 production by macrophages through interrupting TLR2 signaling pathways and inducing macrophage apoptosis. However, the effect of ESAT-6 on T cells remains unexplored. To address this question, we studied the effect of recombinant ESAT-6 and CFP10 on human primary T-cell IFN-gamma secretion and proliferation. ESAT-6, but not CFP10, inhibited IFN-gamma production by T cells stimulated with M. tuberculosis or with anti-CD3 plus anti-CD28, in a dose-dependent manner. ESAT-6 also inhibited T-cell production of IL-17 and TNF-a, but not IL-2. Presence of CFP10 as part of the ESAT-6/CFP10 heterodimer did not affect ESAT-6 inhibition of T-cell IFN-gamma production. ESAT-6 inhibited the proliferation of CD3+ cells in response to TCR stimulation. ESAT-6 decreased T-cell IFN-gamma secretion by mechanisms independent of cytotoxicity or apoptosis. ESAT-6 reduced IFN-gamma mRNA levels by inhibiting the expression of the transcription factors, ATF-2, c-Jun and CREB, which upregulate IFN-gamma gene expression in T cells through binding to the IFN-gamma proximal promoter. ESAT-6, but not CFP10, bound to T cells and inhibited expression of early activation markers without reducing phosphorylation of ZAP70, a proximal TCR signaling molecule. We conclude that ESAT-6 directly inhibits human T-cell responses by affecting TCR signaling pathways downstream of ZAP70.
Similar articles
-
ESAT-6 inhibits production of IFN-gamma by Mycobacterium tuberculosis-responsive human T cells.J Immunol. 2009 Mar 15;182(6):3668-77. doi: 10.4049/jimmunol.0803579. J Immunol. 2009. PMID: 19265145 Free PMC article.
-
Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.Scand J Immunol. 2010 Oct;72(4):349-57. doi: 10.1111/j.1365-3083.2010.02448.x. Scand J Immunol. 2010. PMID: 20883320
-
The Mycobacterium tuberculosis early secreted antigenic target of 6 kDa inhibits T cell interferon-γ production through the p38 mitogen-activated protein kinase pathway.J Biol Chem. 2011 Jul 8;286(27):24508-18. doi: 10.1074/jbc.M111.234062. Epub 2011 May 17. J Biol Chem. 2011. PMID: 21586573 Free PMC article.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
-
ESAT-6 proteins: protective antigens and virulence factors?Trends Microbiol. 2004 Nov;12(11):500-8. doi: 10.1016/j.tim.2004.09.007. Trends Microbiol. 2004. PMID: 15488391 Review.
Cited by
-
Genomic insights into Mycobacterium simiae human colonization.Stand Genomic Sci. 2018 Jan 8;13:1. doi: 10.1186/s40793-017-0291-x. eCollection 2018. Stand Genomic Sci. 2018. PMID: 29340007 Free PMC article.
-
Bacterial metabolism in the host and its association with virulence.Virulence. 2025 Dec;16(1):2459336. doi: 10.1080/21505594.2025.2459336. Epub 2025 Jan 31. Virulence. 2025. PMID: 39890585 Free PMC article. Review.
-
Optimizing antigen selection for the development of tuberculosis vaccines.Cell Insight. 2024 Mar 16;3(3):100163. doi: 10.1016/j.cellin.2024.100163. eCollection 2024 Jun. Cell Insight. 2024. PMID: 38572176 Free PMC article. Review.
-
Different modalities of host cell death and their impact on Mycobacterium tuberculosis infection.Am J Physiol Cell Physiol. 2022 Nov 1;323(5):C1444-C1474. doi: 10.1152/ajpcell.00246.2022. Epub 2022 Oct 3. Am J Physiol Cell Physiol. 2022. PMID: 36189975 Free PMC article. Review.
-
Modulation of cell death by M. tuberculosis as a strategy for pathogen survival.Clin Dev Immunol. 2011;2011:678570. doi: 10.1155/2011/678570. Epub 2011 Jan 4. Clin Dev Immunol. 2011. PMID: 21253484 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous